siRNA, Anti-PAX7, LNA-modified(CAT#: SIRGT19225WQ-LNA)

The product SIRGT19225WQ-LNA is a type of small interfering RNA (siRNA) that targets PAX7 gene and regulates the expression of gene. The siRNA interferes with the expression of PAX7 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001135254.1; NM_002584.2; NM_013945.2
Alternative Names HUP1; PAX7B; RMS2
Related Diseases Alveolar rhabdomyosarcoma
Purification HPLC
Target Gene
Gene ID 5081
Uniprot ID P23759

Related Products